Join Signum Morning Briefing 27 March: Discover how RWE drives better outcomes for safety and regulatory demands

Consulting
Topics to explore
RWE study reveals sustained efficacy of diabetes treatment
Every prescription tells a story. But do you know what happens after the prescription is written?
Read the case
Services
Topics to explore
Understand your patient
Gain clear insights into your patient care with our two top data solutions: Patient Impact Planner and Indication Insights.
Read more
Cases
Examples of our work
Browse the articles in this section to see examples of our work for other pharmaceutical companies.

If you’re interested in a specific service area, use the links on the right to navigate our portfolio.
Show me the cases
Topics to explore
Medice’s ADHD app launch: a digital health success story
Learn how Medice launched a commercially successful digital health app for ADHD families in Scandinavia.
Read the case
Insights
Forward Thinkers Review 2.0
Want to know what it takes to grow in the Nordic pharma industry over the next 3-5 years?
Download the report
Pharma Insights
We provide you with solid insight on which to base your strategy and tactical decisions. Some in a written format, others in the form of webinars.

Discover your options to the right - and let us know if you need anything else.
Sign up for our newsletter
Topics to explore
About
Career at Signum
Would you like to be part of creating solutions for life science companies?
See open positions
Who are we
Decades of experience, in-depth knowledge of the Nordic markets and innovative data science make it possible for us to cut through the complexity to find the solutions you need for sound decision making.
Learn more
Topics to explore
- Our team
- Contact
- Jobs
- Newsletter
Get in touch

About
>
Our team
>
Benedikte Irene von Osmanski

Benedikte Irene von Osmanski

Industrial PhD Student

Benedikte graduated as a medical doctor from the University of Copenhagen in 2020. She brings experience from Clinical Pharmacology and is highly interested in pharmacoepidemiology. In April 2021, Benedikte started her Industrial PhD project which is conducted in collaboration between Copenhagen Phase IV Unit and Signum. The project aims to evaluate and develop new methods to assess drug effectiveness based on real-world data.